MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
49.82
+0.49 (0.99%)
Nov 20, 2024, 4:00 PM EST - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $3.14 billion as of November 21, 2024. Its market cap has increased by 39.33% in one year.
Market Cap
3.14B
Enterprise Value
2.66B
1-Year Change
39.33%
Ranking
Category
Stock Price
$49.82
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.14B, an increase of 87,220.07%. That is a compound annual growth rate of 1,055.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.14B | -13.20% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acadia Healthcare Company | 3.44B |
| Denali Therapeutics | 3.42B |
| Neogen | 3.35B |
| BrightSpring Health Services | 3.27B |
| Verona Pharma | 3.11B |
| Agios Pharmaceuticals | 3.06B |
| PTC Therapeutics | 3.04B |
| Bausch Health Companies | 3.00B |